These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Drug treatment of heart insufficiency]. Follath F Schweiz Med Wochenschr; 1988 Dec; 118(50):1886-91. PubMed ID: 3065935 [TBL] [Abstract][Full Text] [Related]
23. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII]. Dessì-Fulgheri P; Paci MV; Rappelli A Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751 [TBL] [Abstract][Full Text] [Related]
29. [Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency]. Weber S; Pailleret JJ; Cattan S; Guérin F; Degeorges M Ann Med Interne (Paris); 1985; 136(3):256-60. PubMed ID: 3927808 [TBL] [Abstract][Full Text] [Related]
30. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Abrams WB; Davies RO; Ferguson RK Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221 [TBL] [Abstract][Full Text] [Related]
31. [Modern therapy of cardiac insufficiency]. Stojsić D; Jelkić N Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395 [TBL] [Abstract][Full Text] [Related]
32. [Combination of anti-angina drugs]. Silber S Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981 [TBL] [Abstract][Full Text] [Related]
33. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials. Ramahi TM; Lee FA Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432 [TBL] [Abstract][Full Text] [Related]
34. The role of organic nitrates in the treatment of heart failure. Elkayam U; Karaalp IS; Wani OR; Tummala P; Akhter MW Prog Cardiovasc Dis; 1999; 41(4):255-64. PubMed ID: 10362348 [TBL] [Abstract][Full Text] [Related]
35. Digitalis and non-ACE inhibitor vasodilators in heart failure. Chatterjee K Cardiol Clin; 1989 Feb; 7(1):99-118. PubMed ID: 2650876 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacologic interactions with nitrates in patients with, or at risk of, cardiac decompensation]. Filardi PP; Chiariello M G Ital Cardiol; 1996 Sep; 26(9):1085-8. PubMed ID: 9036050 [No Abstract] [Full Text] [Related]
37. Clinical studies on the therapy of heart failure using ACE-inhibitors and AT1-receptor blockers--does combination treatment make sense? Hennig L Clin Nephrol; 2002 Jul; 58 Suppl 1():S7-11. PubMed ID: 12227730 [TBL] [Abstract][Full Text] [Related]
38. [Drug treatment of cardiac insufficiency with systolic dysfunction]. Follath F Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344 [TBL] [Abstract][Full Text] [Related]
39. The role of vasodilator therapy in the treatment of severe chronic heart failure. Packer M Drugs; 1986; 32 Suppl 5():13-26. PubMed ID: 3552590 [TBL] [Abstract][Full Text] [Related]